JPRN-UMIN000003821已完成未知
Efficacy of human atrial natriuretic peptide for the patients with severe sepsis; Impact on prevention against acute kidney injury - SANP
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients are excluded (a)if they have already introduced maintenance HD before admission, (b)have got abdominal surgery for perforation of digestive tract, (c)have fallen in sepsis for more than 48 hours before the start of antibiotic therapy, (d)can't get out of septic shock within 72 hours after the start of antibiotic therapy, (e)have severe chronic heart failure as NYHA III or IV, (f)known pregnancy, (g)expected stay in the intensive care unit of less than 3 days, or (h)poor chance of survival.
研究者
相似试验
已完成
3 期
Effect of human atrial natriuretic peptide for prevention of atrial fibrillation after CABG: a randomised controlled trialmyocardial infarction, anginaJPRN-UMIN000002620ihon University school of medicine700
已完成
不适用
Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancerColorectal cancerJPRN-UMIN000025877Osaka University Graduate School of Medicine5
已完成
2 期
Clinical Research; Efficacy of human atrial natriuretic peptide (hANP) on lung cancer surgery Basic Research; Efficacy of hANP on lung cancerlung cancerJPRN-UMIN000004880Department of General Thoracic Surgery, Osaka University Graduate School of Medicine1,000
已完成
不适用
ow dose atrial natriuretic peptide provides effective renal protection from acute kidney injury after aortic arch surgery: a randomised controlled trialacute kidney injuryJPRN-UMIN000011650Kawasaki Saiwai Hospital43
已完成
2 期
Human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trialnon-small cell lung cancerJPRN-UMIN000018480ational Cerebral and Cardiovascular Center332